Skip to main content
Transgene Biotek Ltd. logo

Transgene Biotek Ltd. — Investor Relations & Filings

Ticker · 526139 ISIN · INE773D01018 BSE.NS Professional, scientific and technical activities
Filings indexed 1 across all filing types
Latest filing 2026-05-15 Regulatory Filings
Country IN India
Listing BSE.NS 526139

About Transgene Biotek Ltd.

https://www.transgenebiotek.com/

Transgene Biotek Ltd. focuses on the research and development of therapeutic solutions within the life sciences sector. The company specializes in oncology, RNA interference (RNAi) technology, and advanced drug delivery systems. Its research portfolio includes the development of monoclonal antibodies, vaccines, and biogenerics designed to treat complex medical conditions. A core technological focus is the Trabi-ORAL platform, which facilitates the oral delivery of proteins and peptides, including insulin. The company advances therapeutic candidates from discovery through clinical development, aiming to provide innovative treatments for chronic diseases and improve patient outcomes through specialized medical research.

Recent filings

Filing Released Lang Actions
Transgene Biotek Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve To Consider and approve the ....
Regulatory Filings Classification · 60% confidence The document is a formal notice to the exchange informing of an upcoming Board of Directors meeting to approve audited financial results. It does not contain any financial results itself, nor does it announce changes in Board composition or solicit shareholder votes. It is a standard regulatory announcement to the stock exchange, fitting the fallback category for miscellaneous regulatory filings.
2026-05-15 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.